Status:
COMPLETED
Central Venous Access Study
Lead Sponsor:
Hackensack Meridian Health
Conditions:
Central Line Catheters
Eligibility:
All Genders
22+ years
Brief Summary
The aim of this study is to document clinicians variation in practice in comparison to standard guidelines by the Medical Center's approved Evidence-based Practice (EBP) guidelines, policies, and proc...
Detailed Description
This will be a single site retrospective (non-experimental) study utilizing the electronic medical record, both descriptive and correlational methods. There will be two outcomes: 1. The outcomes ass...
Eligibility Criteria
Inclusion
- • Adult patients in Medical Intensive Care Unit (MICU), Coronary Care Unit (CCU), Cardiac Surgical Intensive Care Unit (CSICU), Surgical Intensive Care Unit (SICU) with either CVCs, PICCs, or HD catheters.
Exclusion
- • Pediatric (including neonates), obstetric and gynecology, medical-surgical, and oncology patients.
Key Trial Info
Start Date :
April 11 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 7 2022
Estimated Enrollment :
217 Patients enrolled
Trial Details
Trial ID
NCT03480542
Start Date
April 11 2017
End Date
April 7 2022
Last Update
June 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hackensack University Medical Center
Hackensack, New Jersey, United States, 07601